Literature DB >> 23572277

Expression of secreted frizzled-related protein 1 and 3, T-cell factor 1 and lymphoid enhancer factor 1 in clear cell renal cell carcinoma.

Tamara Nikuševa-Martić1, Ljiljana Serman, Martina Zeljko, Zeljko Vidas, Slavko Gašparov, Hrvojka Marija Zeljko, Marin Kosović, Nives Pećina-Šlaus.   

Abstract

Frequency and mortality of renal cell carcinoma (RCC) are increasing for decades. However, the molecular background of RCC tumorigenesis is still poorly understood. In current study we investigated the expression of TCF/LEF and SFRP family members (SFRP1 and SFRP3) to gain a better understanding of biological signaling pathways responsible for epidemiology and clinical parameters of clear cell RCC (cRCC). Thirty-six pairs of paraffin-embedded clear cRCC and adjacent nontumoral tissues samples using immunohistochemistry (IHC) were analyzed and compared with corresponding clinicopathological parameters. Immunohistochemistry indicated statistically significant decreased SFRP3 expression in tumor tissues but no consistency in SFRP1 expression in analyzed normal and tumor tissue. The TCF1 expression level was significantly weaker in normal tissue compared to tumor samples while LEF1 protein levels were significantly weaker in tumor tissue. To our knowledge, this is the first report on analysis of the expression of transcription factors TCF1 and LEF1 in clear cell renal cell carcinoma and their comparison with Wnt signal pathway antagonists belonging to SFRP family.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572277     DOI: 10.1007/s12253-013-9615-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

Review 1.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

Review 2.  Secreted WNT antagonists as tumor suppressors: pro and con.

Authors:  Jeffrey S Rubin; Michal Barshishat-Kupper; Farhana Feroze-Merzoug; Zong Fang Xi
Journal:  Front Biosci       Date:  2006-09-01

Review 3.  The Wnt signaling pathway and its role in tumor development.

Authors:  B Lustig; J Behrens
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-18       Impact factor: 4.553

4.  Evaluation of mouse Sfrp3/Frzb1 as a candidate for the lst, Ul, and Far mutants on chromosome 2.

Authors:  C L Peichel; C A Kozak; F P Luyten; T F Vogt
Journal:  Mamm Genome       Date:  1998-05       Impact factor: 2.957

Review 5.  TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.

Authors:  Helen Brantjes; Nick Barker; Johan van Es; Hans Clevers
Journal:  Biol Chem       Date:  2002-02       Impact factor: 3.915

6.  Role of secreted frizzled-related protein 3 in human renal cell carcinoma.

Authors:  Hiroshi Hirata; Yuji Hinoda; Koji Ueno; Shahana Majid; Sharanjot Saini; Rajvir Dahiya
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

Review 7.  HMG box containing transcription factors in lymphocyte differentiation.

Authors:  M W Schilham; H Clevers
Journal:  Semin Immunol       Date:  1998-04       Impact factor: 11.130

Review 8.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

9.  The Wnt antagonist sFRP1 in colorectal tumorigenesis.

Authors:  Germaine M Caldwell; Carolyn Jones; Karl Gensberg; Shamem Jan; Robert G Hardy; Philip Byrd; Shaheen Chughtai; Yvonne Wallis; Glenn M Matthews; Dion G Morton
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

10.  Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.

Authors:  Michelle L Gumz; Hongzhi Zou; Pamela A Kreinest; April C Childs; Leandra S Belmonte; Shauna N LeGrand; Kevin J Wu; Bruce A Luxon; Mala Sinha; Alexander S Parker; L-Z Sun; David A Ahlquist; Christopher G Wood; John A Copland
Journal:  Clin Cancer Res       Date:  2007-08-15       Impact factor: 12.531

View more
  4 in total

1.  Inhibition of miR‑194 suppresses the Wnt/β‑catenin signalling pathway in gastric cancer.

Authors:  Yin Peng; Xiaojing Zhang; Huijuan Lin; Shiqi Deng; Yong Huang; Ying Qin; Xianling Feng; Ruibin Yan; Yanqiu Zhao; Yulan Cheng; Yanjie Wei; Jian Wang; Wangchun Chen; Xinmin Fan; Hassan Ashktorab; Duane Smoot; Stephen J Meltzer; Song Li; Zhong Zhang; Zhe Jin
Journal:  Oncol Rep       Date:  2018-10-08       Impact factor: 3.906

2.  Combination of Inositol Hexaphosphate and Inositol Inhibits Liver Metastasis of Colorectal Cancer in Mice Through the Wnt/β-Catenin Pathway.

Authors:  Xiaohan Liu; Cuiping Liu; Chen Chen; Wenna Sun; Yifan Ci; Qianqian Li; Yang Song
Journal:  Onco Targets Ther       Date:  2020-04-16       Impact factor: 4.147

3.  A comprehensive analysis of Wnt/β-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer.

Authors:  Yan-Lei Li; Yu-Fen Jin; Xiu-Xia Liu; Hong-Jun Li
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

Review 4.  Wnt signaling in kidney: the initiator or terminator?

Authors:  Ping Meng; Mingsheng Zhu; Xian Ling; Lili Zhou
Journal:  J Mol Med (Berl)       Date:  2020-09-17       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.